Skip to main content
Fig. 3 | Advances in Rheumatology

Fig. 3

From: CD19+CD24highCD27+ B cell and interleukin 35 as potential biomarkers of disease activity in systemic lupus erythematosus patients

Fig. 3

Association of the proportion of CD19+CD24hiCD27+ B cells with SLE-related parameters. A–D Correlation of the proportion of CD19+CD24hiCD27+ B cells with level of complement C3, C4, ESR and monocyte number in peripheral blood. E The proportion of CD19+CD24hiCD27+ B cells from anti-dsDNA negative patients (n = 30) and anti-dsDNA positive patients (n = 11). F–H The proportion of CD19+CD24hiCD27+ B cells in SLE patients with rash (n = 24) and without rash (n = 17); with hematological disorders (n = 19) and without hematological disorders (n = 22); with nephritis (n = 24) and without nephritis (n = 17). *P < 0.05, **P < 0.01, ***P < 0.001; ns, not significant

Back to article page